Precise control of nitric oxide concentration in the inspired gas of continuous flow respiratory devices

Pediatric Pulmonology

Volumn 22, Issue 3, 1996, Pages 182-187

  Hudome, Susan M ^a   Ergenekon, Ebru N ^a   Darrow, Kimberly A ^a   Richard, Russell B ^a   Snider, Michael T ^a   Marks, Keith H ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

dual monitor; NO monitoring device; NO therapy; NO2 monitoring device; Persistent pulmonary hypertension

Indexed keywords

METHEMOGLOBIN; NITRIC OXIDE; NITROUS OXIDE;

ARTICLE; CALCULATION; CHEMOLUMINESCENCE; ELECTROCHEMICAL DETECTION; GAS FLOW; HUMAN; INHALATIONAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; VENTILATOR;

CHEMILUMINESCENT MEASUREMENTS; ELECTROCHEMISTRY; HUMANS; HYPERTENSION, PULMONARY; MONITORING, PHYSIOLOGIC; NITRIC OXIDE; RESPIRATORY THERAPY;

EID: 0029903974     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(199609)22:3<182::AID-PPUL7>3.0.CO;2-R     Document Type: Article

References (32)

1. Kinsella JP, Abman SH. Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn. J Pediatr. 1995; 126:853-864.
2. Finer NN, Etches PC, Kastrama B, Tierney AJ, Peliowski A, Ryan A. Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response. J Pediatr. 1994; 124:302-307.
3. Kinsella JP, Abman SH. Inhalational nitric oxide therapy for persistent pulmonary hypertension of the newborn. Pediatrics. 1993; 91:997-998.
4. Adatia I, Thompson J, Landzberg M, Wessel DL. Inhaled nitric oxide in chronic obstructive lung disease. Lancet. 1993; 341:307-308.
5. Rossaint R, Falke KJ, López F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med. 1993; 328:399-405.
6. Haydar A, Malhere T, Mauriat P, Journois D, Pouard P, Denis N, Lefébvre D, Safran D, Vouhé P. Inhaled nitric oxide for postoperative pulmonary hypertension in patients with congenital heart defects. Lancet. 1992; 340:1545.
7. Abman SH, Kinsella JP, Schaffer MS, Wilkening RB. Inhaled nitric oxide in the management of a premature newborn with severe respiratory distress and pulmonary hypertension. Pediatrics. 1993; 92:606-609.
8. Journois D, Pouard P, Mauriat P, Malhére T, Vouhé P, Safran D. Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects. J Thorac Cardiovasc Surg. 1994; 107:1129-1135.
9. Wessel DL, Adatia I, Giglia TM, Thompson JE, Kulik TJ. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation. 1993; 88[part 1]:2128-2138.
10. Frostell CG, Blomqvist H, Hedenstierna G, Lundberg J, Zapol WM. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing sytemic vasodilation. Anesthesiology. 1993; 78:427-435.
11. Zapol WM, Falke KJ, Rossaint R. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med. 1993; 329:207.
12. Roberts Jr JD. Lang P, Bigatello LM, Vlahakes GJ, Zapol WM. Inhaled nitric oxide in congenital heart disease. Circulation. 1993; 87:447-453.
13. Roberts JD, Polander DM, Lang P, Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 1992; 340:818-819.
14. Clutton-Brock J. Two cases of poisoning by contamination of nitrous oxide with higher oxides of nitrogen during anaesthesia. Br J Anaesth. 1967; 39:388-392.
15. Church DF, Pryor WA. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect. 1985; 64:111-126.
16. Sneddon JM. The oxides of nitrogen. Leslie GB, Lunau FW, eds. Indoor Air Pollution: Problems and Priorities. New York: Cambridge University Press, 1992; 63-76.
17. Seinfeld JH. Atmospheric Chemistry and Physics of Air Pollution. New York: John Wiley & Sons, 1986:175.
18. Moncada S, Palmer J, Higgs EA. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharm Rev. 1991; 43:109-142.
19. Beckman JS, Beckman TW, Chen J. Apparent hydroxyl radical production by peroxynitrite; Implications for endothelial injury from nitric oxide and Superoxide. Proc Natl Acad Sci USA. 1990; 87:1620-1624.
20. Mercier J-C, Zupan V, Dehan M, Renaudin M-H, Bouchet M, Raveau C. Device to monitor concentration of inhaled nitric oxide. Lancet. 1993; 342:431-432.
21. Wessel DL, Adatia I, Thompson JE. Hickey PR. Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertension. Crit Care Med. 1994; 22:930-938.
22. Gomez MR, Moon JK, Jarriel WS. Evaluation of a dynamic system for delivery of nitric oxide for the treatment of persistent pulmonary hypertension (PPHN). Pediatr Res. 1994; 35:334A.
23. Watkins DN, Jenkins IR, Rankin JM, Clarke GM. Inhaled nitric oxide in severe acute respiratory failure - its use in intensive care and description of a delivery system. Anaesth Intens Care. 1993: 21:861-875.
24. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986; 1:307-310.
25. Miller CC. Chemiluminescence analysis and nitrogen dioxide measurement. Lancet. 1994; 343:300-301.
26. Foubert L, Fleming B, Latimer R, Jonas M, Oduro A, Borland C, Higenbottam T. Safety guidelines for use of nitric oxide. Lancet. 1992; 339:1615-1616.
27. Bouchet M, Renaudin MH, Raveau C, Mercier JC, Dehan M, Zupan V. Safety requirements for use of inhaled nitric oxide in neonates. Lancet. 1993; 341:968-969.
28. Miller OI, Celermajer DS, Deanfield JE, Macrae DJ. Guidelines for the safe administration of inhaled nitric oxide. Arch Dis Child. 1994; 70:F47-F49.
29. Petros AJ, Cox P, Bohn D. A simple method for monitoring the concentration of inhaled nitric oxide. Anaesthesia. 1994; 49:317-319.
30. Kinsella JP, Neish SR, Shaffer E, Abman SH. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 1992; 340:819-820.
31. Kinsella JP, Neish SR, Dunbar I, Shaffer E, Abman SH. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J Pediatr. 1993: 123:103-108.
32. Miyamoto K, Aida A, Nishimura M, Nakano T, Kawakami Y, Ohmori Y, Ando S, Ichida T. Effects of humidity and temperature on nitrogen dioxide formation from nitric oxide. Lancet. 1994; 343:1099-1100.